- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Minimally Invasive Surgery in Gynecologic Cancers
Deadline: 31 December 2026
Immunotherapy with Checkpoint Inhibitors for Non-Small-Cell Lung Cancer (2nd Edition)
Deadline: 30 December 2026
Cancer Cell Death and Immune Response
Deadline: 25 December 2026
Tumor–Microbiota Crosstalk: Immune Modulation and Resistance to Cancer Therapies
Deadline: 25 December 2026
Epitranscriptomics and the Tumor Microenvironment
Deadline: 25 December 2026
Hematological Malignancies: From Translational Discoveries to Clinical Trends
Deadline: 20 December 2026
Cancer Genetics and Epigenetics: Their Roles and Clinical Implications (2nd Edition)
Deadline: 20 December 2026
The State of the Art in Cardio-Oncology
Deadline: 20 December 2026
Retroviruses and Cancer Development: Molecular Mechanisms and Therapeutic Prospects
Deadline: 20 December 2026
Clinical Treatment and Prognostic Factors of Urologic Cancer
Deadline: 15 December 2026
The Evolving Landscape of Squamous Cell Carcinoma of the Anal Canal: State of the Art, Current Challenges and Future Perspectives
Deadline: 15 December 2026
Treatment-Induced Metabolic and Inflammatory Responses in Cancer
Deadline: 15 December 2026
of 262

